Skip to main content
Clinical Trials/NCT05784571
NCT05784571
Completed
N/A

Assessment of Body Composition and Physical Function in Older Adults With Obesity

Pennington Biomedical Research Center1 site in 1 country40 target enrollmentMarch 13, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Body Composition
Sponsor
Pennington Biomedical Research Center
Enrollment
40
Locations
1
Primary Endpoint
Fat Mass
Status
Completed
Last Updated
last year

Overview

Brief Summary

Sarcopenia, which is the loss of muscle mass and strength or physical function, naturally occurs in aging. In sarcopenic obesity, growth of muscle mass and increments in strength do not parallel weight gain, and places older adults at increased risk of falls, fractures, physical disability, frailty, and mortality from too low muscle strength relative to body size. The goal of the study is to assess body composition and physical function in older adults with obesity.

Detailed Description

This is a cross-sectional study in 40 adults aged 60 to 80 years with obesity. Body composition, physical function, and insulin resistance will be measured. Subjects who satisfy the eligibility criteria and sign the informed consent will be enrolled. Subjects will complete an assessment of body composition by bioelectrical impedance analysis and tests of physical performance. Blood will be drawn for measurement of fasting glucose and insulin.

Registry
clinicaltrials.gov
Start Date
March 13, 2023
End Date
June 1, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Candida Rebello

Assistant Professor

Pennington Biomedical Research Center

Eligibility Criteria

Inclusion Criteria

  • Body mass index \> 30kg/m2
  • Age 60 - 80 years

Exclusion Criteria

  • self-reported history of diabetes, or cancer or significant cardiovascular or hepatic or renal disease or dysfunction.
  • clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, or celiac disease.

Outcomes

Primary Outcomes

Fat Mass

Time Frame: One day

Measurement of fat mass

Fat-free Mass

Time Frame: One day

Measurement of fat-free mass

Modified Physical Performance Test

Time Frame: One day

Test for assessing physical performance. The scale ranges from 0 to 36 and higher score indicates a better outcome

Secondary Outcomes

  • Hand Grip Strength(One day)
  • 6-minute Walk Test(One day)
  • Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)(One day)

Study Sites (1)

Loading locations...

Similar Trials